Bristol-Myers Squibb 
BMY has not deviated this far my selected simple-moving average since the early 2000s. It is currently in a personal buy zone in the low $40s. It may trade sideways for some time, but my hope is patience pays off (including the dividend).
Target #1 = Gap fill to $56.
Target #2 = Gap fill to $70.
BMY has not deviated this far my selected simple-moving average since the early 2000s. It is currently in a personal buy zone in the low $40s. It may trade sideways for some time, but my hope is patience pays off (including the dividend).Target #1 = Gap fill to $56.
Target #2 = Gap fill to $70.
Note
Target #1 reached for a 40% gain.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.